KYMR Kymera Therapeutics posts wider than expected Q4 2025 loss sending shares down 259 percent today CAC Camden Natl posts nearexpected Q4 2025 EPS shares slip 04 on mild investor caution Valley VLYPO Stock Is It Reversing Valley posts 47 EPS beat topping street forecasts